Frequently asked questions
Zach Sobiech, an 18-year-old from Stillwater, Minnesota, was never far from his family, friends and his guitar. Upon his diagnosis of osteosarcoma, a bone cancer, in May 2009, Zach turned to music in a big way by writing and performing songs as a way to say goodbye, at first to his friends and family, and then to the world. Millions who heard Zach’s hit song “Clouds” were inspired by his heartfelt lyrics and irresistible positivity in the face of adversity.
Zach’s Movement is a community of people from all over the world who are committed to finish what Zach started - finding better treatments and a cure for osteosarcoma by raising money for research.
Zach’s mission was to make sure no other family would lose a child to osteosarcoma. Before Zach passed away in 2013, he and his family started the Zach Sobiech Osteosarcoma Fund at Children’s Cancer Research Fund. To date, the Zach Sobiech Osteosarcoma Fund has raised over $2.1 million to help childhood cancer researchers tackle osteosarcoma.
Children’s Cancer Research Fund (CCRF) supports the brightest scientists whose ideas make the greatest impact for children with cancer. CCRF also supports vital family services and advocates for childhood cancer education and awareness. Since 1981, Children’s Cancer Research Fund has granted over $186 million to research, education and patient and family services.
Many of the standard treatments for osteosarcoma haven’t improved since the 1970s. Kids today receive harsh, outdated treatments that have long-lasting side effects and even raise a child’s risk for secondary cancers.
Zach’s Movement is changing that. Your fundraising is helping scientists develop better, safer treatments for osteosarcoma.
100% of all donations to the Zach Sobiech Osteosarcoma Fund support research for better treatments for this deadly disease.
Yes! Every $1 donated to Children’s Cancer Research Fund helps researchers secure an average of $18 in funding from the government and other sources. In addition, CCRF helps jump-start new research projects and fuel preclinical studies that are required before a new treatment can be used.